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ABSTRACT 
The current development of antibiotic resistance calls for prudent use of antibiotic prescription. 
Methods of investigating antibiotic overconsumption, include identifying areas of misuse or 
overuse, as well as implementing recommendations and guidelines. The efficacy of antibiotic 
prophylaxis prior to dental implant surgery is debated. However, the rationale for restrictive 
antibiotic prophylaxis is often based on tradition rather than actual knowledge of negative 
consequences. Therefore, the general aim of this thesis is to investigate the rationale for 
restrictive antibiotic prophylaxis in implant dentistry and to determine actual prescription 
behavior.  
Study I: The aim of Study I was to investigate the microbiological consequences on oral 
microflora in terms of selection for resistance extent, and to determine the ecological 
disturbance after a single dose of 2 g amoxicillin. Thirty-three healthy participants were given 
a single dose of 2 g amoxicillin. Saliva was collected prior to administration of antibiotics (day 
1), and on days 2, 5, 10, 17 and 24. A large ecological disturbance among oral aerobic 
microflora was observed. The proportion of viridians streptococci with reduced susceptibility 
to amoxicillin was significantly increased on days 2 and 5 (P = 0.00 and P = 0.04, respectively). 
Study II: The aim of Study II was to investigate antibiotic prophylaxis prescription behaviors 
among dentists placing dental implants, and to check the influence of scientific reviews 
published in 2010. Questionnaires were distributed during two time periods (2008 and 2012). 
The questionnaires were sent to eligible dentists (120 in 2008, 161 in 2012) in the Stockholm 
region, Sweden. In 2008, 88% of the dentists routinely prescribed antibiotic prophylaxis during 
implant surgical procedures, while in 2012 this dropped to 74% (P = 0.01). There was a 
significant change in dentists’ prescription patterns with 65% prescribing a single dose 
prophylaxis in 2012, compared to 49% in 2008 (P = 0.04).  
Study III: The aim of Study III was to investigate the effect of antibiotics on the outcome of 
bone augmentation in conjunction with dental implant placement. This was a complex 
systematic review combining the recommended quality assessment methods for systematic 
reviews and primary studies. Selected primary studies were reviewed using a protocol for 
assessment of randomized studies, while scientific evidence was graded according to the 
Grading of Recommendations Assessment, Development and Evaluation (GRADE) 
(Balshem, et al. 2011). The results showed that no relevant systematic reviews pertaining to 
the topic of this study where found. For primary studies, only two studies were regarded as a 
moderate risk of bias.  
Study IV: The aim of Study IV was to determine antibiotic prescription behavior among 
dentists performing bone-augmentation procedures prior to, or in conjunction with dental 
implant surgery, and to check the influence of national recommendations published in 2012. 
In addition, this study also investigated the occurrence of postoperative infection following 
these bone-augmentation procedures. A multi-center retrospective study was performed. Four 
hundred patients’ medical charts were investigated during two time periods (2010-2011 and 
2014-2015). The results showed that, on comparing the two time periods, there was a 
  
significant reduction in the number of patients treated according to national recommendations 
(P = 0.02). Moreover, a significant reduction in the duration of antibiotic treatment was also 
seen (P = 0.03). The number of patients not given antibiotic prophylaxis significantly increased 
(p = 0.00). In addition, the rate of postoperative infections was low and without significant 
difference between both time points (3.5% in 2010-2011 and 7% in 2014-2015). 
In conclusion, single dose of prophylactic antibiotics induces a significant selection of resistant 
strains among oral microflora and causes a large ecological disturbance. There is a wide 
variation in the type, dose and duration of prophylactic antibiotic treatment prior to simple or 
complicated implant surgery. Knowledge regarding the use of antibiotic prophylaxis for 
reducing the risk of infection with bone augmentation procedure in conjunction with dental 
implant placement is lacking. The results of these four studies support a restrictive approach 
to antibiotic prophylaxis and warrant a thorough revisiting of indications for antibiotic 
prophylaxis. In addition, safety aspects pertaining to refraining from single antibiotic use need 
to be fully investigated. There is a need for strict guidelines based on solid scientific evidence 
to promote the rationale for antibiotic usage.  
Keywords: antibiotic prophylaxis, ecological disturbance, oral microflora, antibiotic 
resistance, dental implant, oral bone augmentation, prescription behavior, scientific evidence, 
knowledge gap. 
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1 INTRODUCTION 
Bacteria were amongst the first organisms to live on Earth. They made their appearance over 
three billion years ago in the oceans before colonizing living species. The majority of bacteria 
are essential for life, while only a minor proportion are actually pathogenic. Throughout 
history, harmful bacteria strains have been responsible for infections in the human body, with 
the immune system serving as a first line of defense against pathogenic attacks. As medical 
knowledge grew, many factors such as improvements in diet, sanitation and water purification 
helped strengthen the immune system and prevent infection dissemination. Despite these 
efforts, without antibiotics the major cause of deaths are infectious diseases. Misuse of 
antibiotics though, has further lead to the development of antibiotic resistance and we are now 
facing a massive problem worldwide. Therefore, prescription of antibiotics has become an 
important aspect for medical and dental practice. Bacterial antibiotic resistance has an impact 
on the medical and dental fields, and this thesis will focus on the risks of using antibiotic 
prophylaxis and on antibiotic prescription behaviors in the dental implant field, from a 
microbiological and clinical aspect.  
1.1 ORAL MICROFLORA 
Microorganisms within the human host can be of benefit to our body (Relman 2002), or act as 
commensal organisms meaning they neither benefit nor harm (Dalwai, et al. 2006). The 
resident microflora can prevent colonization of pathogenic organisms, colonization resistance, 
by competing with endogenous nutrients, or with co-factors for microbial growth, or with 
binding sites for microbial attachment on mucosal and dental surfaces (Marsh and Percival 
2006; Nord and Kager 1984; Nord 1990; O'Hara and Shanahan 2006). Moreover, production 
of antibacterial chemicals, and inhibitory factors as a side product of their metabolism, also 
contribute to colonization resistance (Marsh and Percival 2006; Nord and Kager 1984; Nord 
1990; O'Hara and Shanahan 2006). Normal microflora also directly or indirectly effect the 
organism’s normal development of the physiology, nutrition and defence systems (Grubb, et 
al. 1989; Marsh 1989; O'Hara and Shanahan 2006; Rosebury 1962). On the other hand, the 
microflora can act as a reservoir of antibiotic resistant genes (Richard J. Lamont, et al. 2013). 
There are many factors that affect the qualitative and quantitative balance in indigenous 
microflora, including host and environmental factors (Brown, et al. 1975; Ezz El-Arab, et al. 
2006; Nord, et al. 2009; Rashid, et al. 2012; Richard J. Lamont, et al. 2013). Nevertheless, 
bacterial tissue interactions, interbacterial adherence, and interbacterial metabolic interactions 
play an important role in establishing, maintaining and regulating the flora (Schuster 1990; 
Schuster 1999; Schuster and Burnett 1994; Tanner, et al. 1998).  
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The oral cavity is a complex community. It constitutes of different habitats, including teeth, 
gingival sulcus, tongue, cheeks, hard and soft palates, and tonsils. There are more than 750 
bacterial taxa that are naturally colonized in the oral cavity (Jenkinson and Lamont 2005), co-
existing in a balanced microbial ecosystem. From these, oral streptococci predominate the 
microbiota of most individuals (Dalwai, et al. 2006). However, the properties of the mouth as 
a microbial habitat are dynamic and will change over time due to the dietary habits, general 
health, eruption or extraction of teeth, insertion of dentures, placement of orthodontics bands 
and any dental treatment (Faran Ali and Tanwir 2012; Marsh PD 2009; Schuster 1999). The 
most dramatic effect on normal microflora is seen after antibiotic treatment (Nord 1990). 
1.2 ANTIBIOTICS 
The discovery of antibiotics resulted in one of the greatest revolutions in modern medicine. 
Responsible for both treating bacterial infections and reducing mortality and morbidity from 
bacterial diseases. They are today, an essential part of modern medicine and common 
procedures and treatments could not be performed without the availability of potent antibiotics.  
Antibiotics are a compound or substance that kills or slows down the growth of bacteria. 
Antibiotic use is acknowledged as ones of the most commonly used approaches in treating 
bacterial infections. However, as knowledge on the cause of various infections and bacterial 
diseases has grown, new antibiotics consisting of a wider range of antimicrobial compounds 
have been developed. The compound chosen for treatment needs to have the narrowest 
spectrum to cover the most likely pathogens involved. Ideally, the chosen treatment should 
consist of the shortest possible duration for preventing of both clinical and microbiological 
relapse (Oberoi, et al. 2015). This short cycle duration of antibiotic treatment should ideally 
display: a rapid onset of action; bactericidal activity; lack of propensity for development of 
resistant strains; ease of infiltration into the tissues; action against non-dividing bacteria; the 
ability to be unaffected by adverse infection conditions; administration at an optimal dose, and 
an optimal and convenient dosing regimen (Rubinstein 2007).  
Antibiotics vary in their usage and mechanism. They can be classified using different methods 
a) by drug origin (such as synthetic or natural); b) by microbiological range (broad-spectrum 
or narrow-spectrum), c) by type of antibacterial activity (such as killing bacteria or inhibiting 
bacterial growth); or d) by their cellular mechanism of action such as cell wall inhibitors, 
inhibitors of nucleic acid synthesis or protein synthesis inhibitors.  
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From the antimicrobial agents available, only a limited number of systemic antibiotics such as 
amoxicillin, phenoxymethylpenicillin (penicillin-V), clindamycin and metronidazole, are 
commonly used in conjunction with dental surgical procedures (Table 1). Moreover, it has been 
estimated that dental prescriptions are responsible for 5-10 percent of all antibiotic 
prescriptions among patients in some parts in Europe and the USA (Hicks, et al. 2015; 
Holyfield G 2009; HPS and ISD 2016; Norm/Norm-Vet 2015; Pipalova, et al. 2014; Swedres-
Svarm 2016). In Sweden, it is estimated to be six percent (Swedres-Svarm 2016). 
Table 1. Summary of characteristics of the most common antibiotic compounds used in implant dentistry 
(Lund, et al. 2014). © 2016 Khalil D, Lund B, Hultin M. Published in InTech under CC BY 3.0 license. 
Available from: http://dx.doi.org/10.5772/62681. 
 Amoxicillin Clindamycin Metronidazole Penicillin-V 
Spectrum on oral 
flora 
Streptococcus 
Peptostreptococcus 
Actinomyces 
Fusobacterium 
Capnocytophaga 
Streptococcus 
Staphylococcus 
Bacteroids 
Fusobacterium 
Prevotella 
Anaerobic cocci 
Peptostreptococcus 
Clostridium 
Bacteroids 
Prophyromonas 
Prevotella 
Fusobacterium 
Capnocytophaga 
Streptococcus 
Peptostreptococcus 
Actinomyces 
Fusobacterium 
Capnocytophaga 
Effect Time dependent Concentration 
dependent 
Concentration 
dependent 
Time dependent 
Pharmacokinetic 
Absorption (p.o.) 
T½ 
Solubility 
Excretion 
 
90% 
~ 1h 
Water 
Urine 
 
90% 
~ 2,5h 
Fat 
Gall bladder, 
feaces, urine 
 
>95% 
~ 8h 
Fat 
Urine and gall 
baldder 
 
50% 
~ 30 min 
Water 
Urine 
Common side 
effects 
Vomiting, diarrhea, 
nausea, exanthema 
(5%) 
 
Vomiting, 
diarrhea, nausea 
(8%) 
Gastrointestinal 
upset, metallic taste 
(5-10%) 
Diarrhea, nausea 
 
(5%) 
Ecological effects 
Oral 
Gastrointestinal 
 
++ 
++ 
 
+++ 
+++ 
 
++ 
+ 
 
++ 
+ 
P.O. Peroral 
T½ Half life 
+ Mild /no effect, ++ moderate effect, +++ severe effect 
1.3 CONSEQUENCES OF ANTIBIOTIC TREATMENT 
No antibacterial drug is completely non-toxic and thus without side effects or risks. Therefore, 
the prescribing healthcare specialist needs to weigh the potential benefits and risks prior to use. 
The most common side-effect is gastro-intestinal, ranging from a mildly upset stomach to life-
threatening pseudomembranous colitis (Golledge, et al. 1992; Lipsky and Baker 1999; Loffeld 
and Flendrig 1990; Wilton, et al. 1996). Another relatively common adverse effect is 
hypersensitivity – ranging, most commonly, from a mild skin rash or lesion to rarer life-
threatening anaphylactic reactions (Granowitz and Brown 2008). However, a true penicillin 
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allergy, including amoxicillin, is rare with the estimated frequency of anaphylaxis at 1-5 per 
10 000 cases of penicillin therapy, of which 10% of these reactions are fatal (ASCIA 2014; 
Bhattacharya 2010). However, the risk of adverse reaction is known to be increased with broad-
spectrum compounds, and also observed with single dose antibiotic treatment (Thornhill, et al. 
2015). 
 The human normal microflora are often in delicate balance; the optimal distribution of the 
different microorganisms is considered to be important for health maintenance. Administration 
of antimicrobial agents commonly causes a disturbance in this microflora. This disturbance, a 
decrease in the number of microorganisms present and also reduced diversity, is not only due 
to the spectrum of antimicrobial agents, but is also affected by rate of absorption, route of 
elimination, possible enzymatic inactivation and/or whether they bind to human tissue and 
fluids (Sullivan, et al. 2001). Consequently, the disturbance leads to an overgrowth of bacteria 
with natural resistance, reduces host colonization resistance and establishes new resistant 
pathologic bacteria (Figure 1) (Nord 1990; Sullivan, et al. 2001; Van der Waaij and Nord 2000). 
The outcome of antimicrobial treatment is thus dependent on individual variation in normal 
microflora (Sullivan, et al. 2001).  
 
 
 
 
 
 
 
 
 
 
Figure 1. The effect of antibiotic treatment on the ecology of the normal microflora (Nord 1990; Sullivan, et al. 
2001; Van der Waaij and Nord 2000). © 2016 Khalil D, Lund B, Hultin M. Published in InTech under CC BY 
3.0 license. Available from: http://dx.doi.org/10.5772/62681. 
 
Overgrowth of microorganisms 
with natural resistance 
• Oportunistic infections↑ 
• Patient shedding↑ 
• Risk for dissemination↑ 
The number of microorganisms reduced 
Establishment of new resistant 
pathogenic bacteria 
• Promotes colonization 
• Reservoir for resistance 
gene 
Reduction of host colonization 
resistance 
• Competition of nutrients↓ 
• Competition of space↓ 
• Eradication of protective 
bacteria 
• Loose diversity 
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Another negative aspect of the frequent use of antibiotics is the financial demand it places on 
the healthcare system. A previous study suggested that while individual costs for antibiotic 
treatment may be low, the potential cost to the American healthcare system may reach to over 
$150 million annually (Lockhart, et al. 2013). Moreover, resistance to antibiotics results in 
increased cost to patients, healthcare systems and society due to the need for more tests, new 
and more costly medicines, longer hospital stays, lengthy sick leave or even premature death 
(Reactgroup 2008).  
1.4 ANTIBIOTIC RESISTANCE 
Antibiotic resistance has become a global health problem. The World Health Organization 
(WHO) stated that the golden age of antibiotic therapy is now coming to an end (WHO 2015); 
some researchers even believe that the end is already here. The World Economic Forum stated 
that antibiotic resistance has major societal risks (WEF 2017), and that the development of 
resistant infections result in thousands of deaths and millions of dollars spent on healthcare 
every year (O’Neill 2014). Therefore, a cautious approach towards prescribing antibiotics 
needs to be taken in order to try to limit further development of antibiotic resistance. It has 
previously been suggested, although not shown, that a shorter antibiotic treatment regimen 
reduces the risk of developing antibiotic resistance (Guillemot, et al. 1998). In a recent study, 
there was a significant increase in the number of oral streptococci with reduced susceptibility 
against amoxicillin already after a 3-day treatment course (Chardin, et al. 2009). This suggests 
that short-term antibiotic treatment may also pose a marked risk for inducing antibiotic 
resistance. Another serious problem with the development of oral bacterial resistance is that 
the commensal flora may transfer resistance genes to other more pathogenic bacteria such as 
Streptococcus pneumonia and Streptococcus pyogenes (Dowson, et al. 1990; Jonsson and 
Swedberg 2006).  
Pathogens are different in their susceptibility to antibiotics - resistance to one antibiotic may 
not necessarily mean lack of sensitivity to another (Drlica and Perlin 2011). Antibiotic 
resistance is categorized into three major types: natural/ intrinsic resistance (the innate ability 
of a bacterial species to resist the activity of a particular antimicrobial agent), or acquired 
resistance (acquisition of new DNA through transformation, transduction or conjugation), or 
genetic resistance (chromosomal mutation) (Dahlén, et al. 2012; Drlica and Perlin 2011). There 
are five mechanisms by which antibiotics exhibit resistance due to chromosomal mutation: 
reduced permeability or uptake, enhanced efflux, enzymatic inactivation, alteration or over-
expression of the drug target, or loss of enzymes involved in drug activation (Dahlén, et al. 
2012; Richard J. Lamont, et al. 2013). Nevertheless, the lowest necessary antibiotic dose needs 
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to be determined to achieve minimal side effects alongside the highest efficacy to block cell 
growth (Drlica and Perlin 2011).  
Preventive measures such as developing new antimicrobial agents, conducting surveillance, 
implementing isolation, adapting lab procedures, educating about resistance, improving drug 
administration and improving drug choice are important and could minimize the prescription 
of antibiotics (Foucault and Brouqui 2007; McGowan Jr 2001). However, the multifaceted 
intervention approach seems to be the most efficient in the fight against antimicrobial resistance 
(Foucault and Brouqui 2007). In fact, coordinated efforts have already initiated by many 
institutes over the world such as the Association for the Prudent Use of Antibiotics (APUA) 
and the World Health Organization (WHO) in reaction to the spread of antimicrobial resistance. 
However, this fight can only be won with the help of government authorities, hospital 
personnel, community practitioners, the pharmaceutical industry, patient awareness and 
researchers.  
1.5 DENTAL IMPLANTS 
Recently, dental implants - titanium devices anchored and integrated into the jawbone - have 
become an established and successful therapeutic option for partially or completely edentulous 
jaws. They have been an alternative treatment for missing teeth for over 40 years (Branemark, 
et al. 1977). Improvements in implant design, surface characteristics, and surgical protocols 
make implants a secure and highly predictable procedure (Moraschini, et al. 2015). The rate of 
edentulism has decreased in Europe due to the development of implant dentistry (Müller, et al. 
2007). It has been estimated that more than 12 million implants are placed every year, globally 
(Albrektsson, et al. 2014). In Sweden it was calculated that, in 2014, the number of implant 
placed yearly were approximately 78,000 in 31,500 patients according to the Swedish Social 
Insurance Agency.  
Implant survival rates were calculated in a recent meta-analysis with a follow up period of up 
to 20 years. Here, the mean cumulative survival value was 94.6%, ranging from 73.4% to 
100%, while implant success rate ranged from 34.9% to 100% (Moraschini, et al. 2015). In this 
review it was not possible to perform meta-analysis for the success rate due to the variation in 
the success criteria used and their heterogeneity; 50% of the included studies in the review 
shared the same criteria, thus the cumulative mean success rate was 89.7%. There are several 
factors known to determine implant success including survival rates, continuous prosthesis 
stability, absence of radiographic bone loss, absence of infection in the peri-implant soft tissues, 
and patient’s subjective evaluation (Albrektsson and Zarb 1998; Albrektsson, et al. 1986; 
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Annibali, et al. 2012; Buser, et al. 1997; Misch, et al. 2008; Smith and Zarb 1989). A bone loss 
of up to 1.5 mm within the first year after dental implant insertion, followed by an additional 
0.1 mm of annual bone loss is acceptable, according to the Albrektsson guidelines for bone 
remodeling (Albrektsson, et al. 1986). However, recently Van Velzen stated that the amount 
of peri-implant bone loss may progress even more rapidly, leading to an increase in incidence 
rate over time (Van Velzen, et al. 2014).  
1.5.1 Bone graft in conjunction with dental implant placement 
Bone remodeling is a critical aspect of implant survival when restoring an implant to full 
functionality. The implant restoration and supporting bone both need to be able to respond to 
the functional demands placed on them. To achieve the best outcome from dental implant 
treatment, adequate bone should be available to support and stabilize the implant. Lack of 
supporting alveolar bone can be due to atrophy, trauma, developmental defect, periodontal 
disease, tooth loss, and infection/ inflammation (Esposito, et al. 2009; Tonetti and Hämmerle 
2008). Therefore, it is common to perform bone augmentation procedures in cases of 
insufficient bone volume either prior to implant placement, or in conjunction with implant 
placement. There are different types of bone grafting materials and techniques with varying 
clinical outcomes to overcome bone deficiencies (Esposito, et al. 2009; Tonetti and Hämmerle 
2008). Ideally, graft materials should provide four properties: an osteoconductive matrix, 
nonviable scaffolding for the ingrowth of bone; osteoinductive factors, chemicals that promote 
bone regeneration and repair; osteogenic cells, that facilitate bone regeneration; and structural 
integrity (Gazdag, et al. 1995). Reconstruction of the atrophic alveolar ridge was first 
performed in 1975 using an autogenous bone graft (Brånemark, et al. 1975). Autograft material 
is considered the “gold standard” since it combines all properties necessary for grafting 
material (Gazdag, et al. 1995; Marx 2007; Scarano, et al. 2006). This grafting material has 
immunologic compatibility, great vascularization potential, will not lead to disease 
transmission, and has a physical and chemical structure similar to the host site (Gulinelli, et al. 
2017). However, the disadvantage of using autograft material is that additional surgical sites, 
prolonged operative and treatment time, risk of neurovascular injury, unpredictable resorption 
of the graft, and decrease in the volume of the donor site (Gazdag, et al. 1995; Liu and Kerns 
2014). Allograft material is initially referred to a bone graft containing living cells harvested 
from an individual of the same species. This type of material is not easily recommended 
because it initiates a cell mediated immune response and it can only survive if the donor is a 
parent or sibling (Urist 1980). A substitute to the fresh allograft is a bone tissue that derived 
from an individual of the same species and which contains no viable cells. This material is 
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prepared by freezing, freeze drying, irradiating or sterilizing the tissue. Allograft has 
osteoinductive and osteoconductive properties, however some studies have reported that its 
lack of osteoinductive properties and very modest osteoconductive responses (Pinholt, et al. 
1994; Solheim 2001; Urist 1980). Although allograft is inferior to autograft, allografts are 
commonly used in orthopedic surgery in patients with large bone defects as autographs are 
either not available in sufficient quantities or their use is accompanied by high morbidity at the 
donor site (Gocke 2005; Simion, et al. 2001). Moreover, xenograft bone material - material 
obtained from a genetically different species than the host - has osteoconductive properties and 
is biocompatible with human recipients (Tadjoedin, et al. 2003; Terheyden, et al. 1999). The 
disadvantage of using it is its lack of osteoinduction properties (Tadjoedin, et al. 2003; 
Terheyden, et al. 1999). One of the most commonly used xenografts is Bio-Oss® (Geistlich 
Pharma AG, Wohlhusen, Switzerland) deproteinized bovine bone mineral that has been treated 
by removing all of its organic material. Bio-Oss structure greatly increases the surface area and 
thus results in a material that is good for osteoconduction, increases angiogenesis and enhances 
new bone growth (Rodriguez, et al. 2003). On the other hand, because of its large porous nature, 
initial stability may be compromised (Su-Gwan, et al. 2001). However, this material has been 
proved to be a workhorse in oral surgery (Kao and Scott 2007). Moreover, other xenograft 
materials are available including coralline hydroxyapatite, chitosan, gusuibu and redalgae (Kao 
and Scott 2007). Alloplastic graft material is a synthetic bone substitute that serves as a physical 
framework for bone ingrowth, having two of the four elements of an ideal graft: 
osteoconduction and osteointegration. There are many synthetic materials available such as 
bioactive glasses, glass ionomers, calcium sulfate and synthetic hydroxyapatite (Moore, et al. 
2001). The use of a mixed type of bone graft - autograft and xenograft – thus has a better effect 
from a biological perspective than using each one separately (Galindo‐Moreno, et al. 2007).  
There are multiple surgical techniques to augment bone volume horizontally or vertically: only 
graft, inlay graft, ridge expansion, distraction osteogenesis. To date, there is insufficient 
evidence regarding which is the most effective. Onlay bone graft is where graft material is lain 
over the treatment area in order to increase the alveolar jawbone width or height (Kahnberg, et 
al. 1989). Inlay graft is  where part of the jawbone is surgically separated and graft material 
sandwiched between the two sections (Keller 1992). Ridge expansion is where the alveolar 
ridge is surgically split then parted, allowing the implant or grafted material, or both, to be 
inserted. Finally, distraction osteogenesis is a where a surgical fracture is made, then gradually 
displaced to increase bone volume (Chin 1999). The gap created during the displacement is 
loaded with immature non-calcified bone. This bone is then allowed to mature. Moreover, there 
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are some procedures associated with bone graft techniques such as placement of a barrier 
membrane that acts as a barrier to prevent soft tissue growth and forms a chamber to guide the 
bone regeneration process in a defect area (Gottlow 1993; Meinig 2010; Retzepi and Donos 
2010). Maxillary sinus procedures are sometimes needed if the available bone for implant 
placement is of reduced alveolar height. Osteotomies where the bone is cut, modified and 
realigned to correct bone deformity can be also incorporated in the graft procedure. These 
different surgical techniques can be used in combination with different graft materials 
(Esposito, et al. 2009). Augmentation procedures can fail to produce adequate bone volume in 
which to place dental implants and do not necessary result in long term survival rates (Tonetti 
and Hämmerle 2008). However, it has been reported in a systematic review that dental implant 
survival rates are high irrespective of whether implants were placed in native or in augmented 
bone  (Al-Nawas and Schiegnitz 2014; Hämmerle, et al. 2002). 
1.5.2 Complications associated with dental implant placement 
Complications with dental implants do occur, and are associated with infection, failure and/or 
implant loss (Albrektsson and Donos 2012; Donos, et al. 2012). Oral postoperative infections 
in healthy patients are commonly wound infections caused by endogenous aerobic and 
anaerobic microorganisms in the oral cavity (Heimdahl and Nord 1990). The reported 
prevalence of postoperative infection after implant installation varies across published studies 
reaching up to 11.5% even with the use of prophylactic antibiotics, (Table 2) (Abu-Ta'a, et al. 
2008; Anitua, et al. 2009; Caiazzo, et al. 2011; Camps-Font, et al. 2015; Esposito, et al. 2010; 
Esposito, et al. 2008; Gynther, et al. 1998; Nolan, et al. 2014). To date, there is no standard 
routine therapeutic approach for postoperative infections that safely predict an improvement in 
the survival and success rates of these implants.  
Dental implant failures are classified, according to Esposito el at. (Esposito, et al. 1998), into 
four different categories: a) biological implant failures which are categorized as early failures 
i.e. failure to achieve osseointegration due to surgical trauma, infection, or lack of primary 
stability (Sakka, et al. 2012), or late failures i.e. failure to maintain the achieved 
osseointegration due to occlusal overload, peri-implantitis, or both (Sakka, et al. 2012), b) 
mechanical implant failures, which include fracture of the implants or suprastructure, c) 
iatrogenic implant failures, where osseointegration is achieved but due to improper implant 
alignment or angulation, or nerve damage, implants have failed, and d) inadequate patient 
adaptation with phonics, esthetic and psychological problems due to dental implants. Implant 
failure may result in the need for implant removal (Sakka, et al. 2012). There are several risk 
factors for implant failures including systematic, local, prosthodontics and genetic factors 
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(Antoun, et al. 2017; Chrcanovic, et al. 2016; Jemt, et al. 2017; Renvert and Quirynen 2015). 
However, some factors shown to be strongly associated with increased risk of dental implant 
failure such as history of periodontitis and smoking habits (Antoun, et al. 2017; Chrcanovic, et 
al. 2016; Jemt, et al. 2017; Renvert and Quirynen 2015).  
Peri-implantitis is the most commonly reported cause of implant failure, defined as 
inflammation in the peri-implant tissue associated with a loss of supporting bone around a 
functioning implant (Lindhe, et al. 2008). Pontoriero et al. discovered in 1994 that bacterial 
plaque accumulation in the soft tissue around dental implants caused inflammatory changes 
(Pontoriero, et al. 1994). Recent reviews have reported wide variations in the prevalence of 
peri-implantitis. Thus the incidence of peri-implantitis may be dependent on diagnostic criteria, 
patient selection and the variation in length of follow up. The complexity of case selection in 
prospective studies might explain the wide variation in the reported prevalence. In 2012, the 
EAO Consensus Conference stated that peri-implantitis occurred in one of five patients within 
five years following implant surgery (Klinge, et al. 2012). A recent review showed the 
prevalence of peri-implantitis varied from 4.2% to 47% of all implants (Tomasi and Derks 
2012; Van Velzen, et al. 2014).   
Table 2. Published studies on the prevalence of postoperative infections after dental implant placement treated 
with systematic antibiotic 
Published studies Study design Number of 
treated patients 
Number of reported 
postoperative 
infection 
Prevelance of 
postoperative 
infection 
(Gynther, et al. 
1998) 
Retrospective 147 9 6.1% 
(Abu-Ta'a, et al. 
2008) 
Prospective RCT 40 1 2.5% 
(Esposito, et al. 
2008) 
Prospective RCT 158 3 1.9% 
(Anitua, et al. 
2009) 
Prospective RCT 52 6 11.5% 
(Esposito, et al. 
2010) 
Prospective RCT 252 4 1.6% 
(Caiazzo, et al. 
2011) 
Prospective RCT 75 0 0 
(Nolan, et al. 
2014) 
Prospective RCT 27 0 0 
(Camps-Font, et 
al. 2015) 
Retrospective 337 22 6.5% 
1.6 ANTIBIOTIC PROPHYLAXIS IN DENTISTRY 
Historically, antibiotic prophylaxis has been offered to patients either with inherent increased 
risk of developing an infection, or because the treatment procedure in itself is coupled with 
increased risk of infection. Examples of putative risk patients, with either increased 
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susceptibility to infection or at risk of developing a serious infection due to a locus minoris, are 
those at risk for infective endocarditis (IE) or those with severe neutropenia. Patients with 
multiple risk factors of which each one by itself might not indicate antibiotic prophylaxis may 
be candidate for prophylaxis because of the additive effect of multiple factors. Suggested risk 
procedures in dentistry, from an infection perspective, are placement of dental implants, 
orthognathic surgery and surgical treatment of jaw fractures. However, the efficacy of 
antibiotic prophylaxis lacks solid scientific evidence and is still under discussion.   
1.6.1 Oral bacteremia 
Bacteremia originating from bacteria within the oral cavity usually occur passive and don’t 
affect the host but may sometimes lead to several severe health consequences. The host’s 
immune response to the bacteria can cause sepsis and septic shock that results in a high 
mortality rate (Singer, et al. 2016). Bacteria can also spread via the blood to different parts of 
the body causing infections distant from the original infection site, such as endocarditis, 
meningitis or osteomyelitis. The incidence of induced bacteremia varies depending on the 
procedure. Recorded incidences range from 2% for a cardiac catheterization, to 88% for 
periodontal surgeries (Durack 1995). However, daily activities such as chewing food and tooth 
brushing also resulted in frequent episodes of bacteremia (Legout, et al. 2012; Lockhart, et al. 
2009; Termine, et al. 2009). These frequent episodes may carry a greater risk for the 
development of infective endocarditis than the transient bacteremia that follows an invasive 
dental procedure (Lockhart, et al. 2008; Lockhart, et al. 2009).  
Antibiotic prophylaxis to prevent infective endocarditis (IE) began to be recommended in 1955 
(Jones, et al. 1955). Since then, several modifications in the recommendations have been 
published. In 2008, the National Institute for Health and Clinical Excellence (NICE) in the UK 
recommended cessation of antibiotic prophylaxis for patients undergoing a dental procedure 
(NICE 2008.). However, antibiotic prophylaxis prior to dental procedures in high-risk patients 
was recommended by the European Society of Cardiology (ESC) guidelines in 2009, and the 
American Heart Association (AHA) guidelines in 2007 (Habib, et al. 2009; Wilson, et al. 
2007). A study performed on data collected in Great Britain two years after the NICE 
recommendations showed that there was no significant increase in the incidence of IE with the 
dramatic decline in antibiotic prescriptions (Thornhill, et al. 2011). Moreover, Dayer reported 
an increase in the incidence of infective endocarditis in England after five years of cessation of 
antibiotic prophylaxis (Dayer, et al. 2015). During the same period, a study performed in the 
UK demonstrated that the incidence of adverse drug reactions associated with antibiotics used 
for IE prophylaxis was much lower than previously estimated (Thornhill, et al. 2015). Although 
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these data do not establish a definite causal link, epidemiologic variation in occurrence cannot 
be ruled out, and the figures call for attention. In 2015, the NICE and the ESC published their 
updated guidelines. The NICE reported that there was insufficient evidence to modify their 
existing guidelines and continued to advise against antibiotic prescription (NICE 2015). The 
European Society of Cardiology continued their guidance to prescribe antibiotic prophylaxis 
for high-risk individuals undergoing high-risk invasive dental procedures using an antibiotic 
regimen that remained unchanged from 2009 (Habib, et al. 2015). In July 2016, NICE added 
the word “routinely” to their recommendations: antibiotic prophylaxis to prevent IE is not 
recommended routinely for patients undergoing dental procedure. Up to date, there are no 
randomized controlled clinical trials in humans supporting antibiotic prophylaxis to prevent IE 
(Thornhill, et al. 2017). In Sweden in 2012, guidelines recommended the cessation of antibiotic 
prophylaxis prescriptions to prevent IE prior to dental procedures. In a recent endocarditis 
report in Sweden, the total number of registered cases gradually increased to reach more than 
500 in the period from 1995 to 2011. After 2011, the number dropped to less than 450 cases 
and then increased again to reach almost 500 cases yearly (Olaison 2017). Regarding the 
microbiological etiology for diagnosed endocarditis, it was reported that 35% of the diagnosed 
cases in 1995 were due to viridians streptococci. This reduced to 25% in 2011-2014 and then 
increased slightly to 27% in 2016 (Olaison 2017). 
However, a recent health economic study reported that the use of antibiotics to prevent IE in 
high-risk patients is likely to be very cost-effective, and even cost saving (Franklin, et al. 2016). 
This is due to the reported serious consequences and high costs associated with development 
of IE and the comparatively low costs associated with the usage of antibiotics (Franklin, et al. 
2016).  Until recently, studies on the rationale for a restrictive approach towards antibiotic 
prophylaxis have been lacking.  
1.6.2 Dental implant placement  
Dental implant procedures are graded as class II surgical procedures (clean-contaminated 
surgery) with local infection rates of 10 to 15% (Figure 2) (Olson, et al. 1984; Peterson 1990). 
The use of prophylactic antibiotics alongside proper surgical technique in clean-contaminated 
surgery has been shown to reduce the incidence of infection to 1% or less (Olson, et al. 1984; 
Peterson 1990). 
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Figure 2. Surgical wound infection classification and the estimated percentage risk for postoperative infections 
(Olson, et al. 1984; Peterson 1990). © 2016 Khalil D, Lund B, Hultin M. Published in InTech under CC BY 3.0 
license. Available from: http://dx.doi.org/10.5772/62681. 
The rationale for prescribing extended antibiotic prophylaxis beyond the day of surgery was 
initially based on empirical tradition. The prophylaxis treatment regimen was introduced by PI 
Brånemark and collaborators during the 1970s. Under their original protocol, dental implants 
were inserted in a two-staged surgical protocol to prevent infection (Branemark, et al. 1977; 
Lekholm 1983). In addition, antibiotic treatment for up to 10 days during the initial healing 
phase following the implant surgery was recommended to prevent postoperative infection and 
early implant failure (Branemark, et al. 1977; Lekholm 1983). During the past several years, 
the recommendation for extended prophylactic antibiotic treatment has been questioned. The 
Swedish Strategic Programme against Antibiotic Resistance (STRAMA) published revised 
recommendations for the use of antibiotics in conjunction with implant surgery (Blomgren, et 
al. 2009). The Swedish agency for Health Technology Assessment (SBU), which is responsible 
for the assessment of several scientific topics in medical and dental healthcare, published a 
review with over 600 references regarding the use of antibiotic prophylaxis in surgery, 
including dental implant procedures (SBU 2010). They could not find any evidence to support 
antibiotic prescription beyond the day of surgery to prevent the risk of postoperative infection 
and implant failure. In Sweden, the use of single dose antibiotic prophylaxis prior to bone 
augmentation procedures in conjunction with dental implant surgery was recommended by the 
national authority in 2012. Therefore, the use of extended antibiotic prophylaxis beyond the 
day of surgery is considered an outdated approach.  
•Class 1: Clean (<2%) 
Elective, nontraumatic surgery, no transection of the respiratory, gastrointestinal, 
and urinary tracts.
•Class 2 Clean-Contaminated (10%-15%) 
Elective surgery entering the respiratory, gastrointestinal, and urinary tracts., no 
significant bacterial contamination. 
•Class 3 Contaminated (20%–30%)
Fresh traumatic injuries, gross spillage from gastrointestinal, and urinary tracts.
•Class 4 Dirty/Infected (50%) 
Established clinical infection, or a traumatic injury for more than 8 hours old. 
Perforation of respiratory, gastrointestinal, and urinary tracts.
Surgical Wound Classification in Relation to Occurrence 
of Microbial Contamination and the Corresponding 
Infection Rates
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The shift from using extended antibiotic prophylaxis dose to a single dose prior to dental 
implant placement has been investigated. However, it is still debated as to whether a single 
dose antibiotic prophylaxis is necessary or not. Several systematic reviews reported that while 
the risk of implant failure, i.e implant loss, was reduced when prophylactic antibiotics were 
used (Ata-Ali, et al. 2014; Chrcanovic, et al. 2014; Esposito, et al. 2013; Rizzo, et al. 2010; 
Sharaf, et al. 2011; Surapaneni, et al. 2016), but the incidence of postoperative infection did 
not significantly minimize (Ata-Ali, et al. 2014; Chrcanovic, et al. 2014; Esposito, et al. 2013). 
On the other hand, recent reviews showed that healthy patients undergoing implant surgery or 
straight forward cases did not benefit from antibiotic prophylaxis (Ahmad and Saad 2012; 
Lund, et al. 2015; Park, et al. 2017; Schwartz and Larson 2007). However, for complex or 
compromised patients, the results were inconclusive (Lund, et al. 2015). These findings were 
accepted by the European Association of Osseointegration (Klinge, et al. 2015). Due to such 
contradictions in the results of clinical studies, differences in quality, and the sheer number of 
uncontrolled variables making it difficult to ascertain cause and effect, the issue of whether 
there is a benefit to using a single dose antibiotic prophylaxis with implant surgery remains 
questionable, and thus general recommendations based on scientific data still cannot be made. 
Despite this, antibiotics continue to be routinely used by dentists during implant surgery (Datta, 
et al. 2014; Deeb, et al. 2015; Froum and Weinberg 2015; Ireland, et al. 2012; Khalil, et al. 
2015; Pyysalo, et al. 2014). 
1.7 IMPORTANCE OF SYSTEMATIC QUALITY ASSESSMENT OF SCIENTIFIC 
PUBLICATIONS AND GUIDELINES 
Research in healthcare has developed rapidly, and stricter demands now mean that guidelines 
are required to be based on scientific observation. Demands are placed on the inclusion of 
evidence-based medicine, or evidence-based care (EBM) when choosing treatment 
interventions. The concept of EBM is an approach that involves critical appraisal of 
interventions based on the best available scientific evidence (Sackett, et al. 1996). However, 
this also means that the caregiver needs to be updated with the latest research in order to choose 
the best available treatment methods. The number of scientific articles published each year 
continues to grow and thus caregivers are required to spend more and more time keeping up to 
date with the latest research in their field. Estimates show that more than 1.4 million medical 
articles are published annually, of which, approximately 10–15 percent are considered to be of 
practical value to patients (SBU 2017). This means that an average of 17–20 primary studies 
would be needed to be read every day in order for caregivers to be updated (Haynes and Sackett 
1995). Thus reviews are commonly used by clinicians as a method of surveying the current 
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medical literature in a time-effective manner. However, in order to determine whether the 
systematic review has omitted important literature, and to adequately appraise the 
trustworthiness of the conclusions, there needs to be strict methodological guidelines (Liberati, 
et al. 2009; Moher, et al. 2009; Whitlock, et al. 2008). The alternative is that every primary 
study in the review would need to be obtained, read and critically assessed independently by 
the reader. One validated and reliable tool that is increasingly being used for the evaluation of 
systematic reviews is AMSTAR (Shea, et al. 2007a; Shea, et al. 2007b; Shea, et al. 2009). It 
has been suggested that pre-existing reviews should, in combination with primary studies, be 
incorporated into new complex systematic reviews (Whitlock, et al. 2008). A strict predefined 
PICO (population, intervention, control and outcome/observation) is mandatory in this process, 
as well as thorough reproducible literature search, transparent exclusion process, and quality 
assessment by independent reviewers, thus resulting in strict inclusion of high-quality 
systematic reviews.  
Clinical guidelines, systematically developed statements to assist practitioners about 
appropriate health care for specific circumstances, act as tools both for reducing variations in 
health care and for improving patient quality of care, which includes prescribing behavior 
(Borowitz and Sheldon 1993; Feder, et al. 1999; O'Brien, et al. 2000). However, the majority 
of guidelines have not undergone a rigorous methodological selection criteria, making it 
difficult for the clinician to follow (Grilli, et al. 2000). Besides efforts to improve quality, 
common standards for reporting guidelines should be followed (Grilli, et al. 2000). Effecting 
change is difficult to achieve when the goal is to change well-established practice patterns 
(Sbarbaro 2001). When firm and clear practice guidelines are available alongside scientific 
supporting evidence, still physician’s acceptance is minimal (Sbarbaro 2001). However, 
acceptance is increased when leading physicians within a community and the local and national 
professional organizations accredit and approve the change and incorporate it into their practice 
(Lomas and Haynes 1988). Therefore, physicians’ prescription behavior can be influenced but 
it will be a slow and challenging process as habit and time are the brutal enemies of change 
(Sbarbaro 2001). 
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2 AIM 
2.1 GENERAL AIM 
 To investigate the rationale for restrictive antibiotic prophylaxis in implant dentistry, 
and the microbiological consequences of antibiotics 
 To investigate the utilization of antibiotic prophylaxis in implant dentistry in order to 
identify areas for overconsumption, and determine the available scientific evidence for 
supporting or opposing its use 
2.2 HYPOTHESES 
 Single doses of antibiotics induce the selection and development of antibiotic bacterial 
resistance strains 
 Prolonged antibiotic prophylaxis beyond the day of surgery is commonly used as a 
prophylactic dose in implant dentistry and thus an area of improvement potential 
 Antibiotic utilization with bone augmentation procedures in implant dentistry is a 
knowledge gap 
2.3 SPECIFIC AIMS 
Study I: Oral microflora and selection of resistance after a single dose of amoxicillin 
 To determine the ecological impact of a single-dose antibiotic prophylaxis, 2 g 
amoxicillin, on host oral microflora  
 To investigate the selection for resistance following a single-dose antibiotic 
prophylaxis, over a period of several weeks  
Study II: Antibiotic prescription patterns among Swedish dentists working with dental 
implant surgery: adherence to recommendations 
 To investigate antibiotic prescription patterns among dentists in Sweden performing 
dental implant placements  
 To assess adherence to and influnce of recent recommendation and scientific reviews 
on antibiotic routines during dental implant surgery 
Study III: Antibiotics and bone augmentation in dental implant installation: a complex 
systematic review 
 To assess the available scientific literature regarding the efficacy of antibiotic use 
during bone augmentation procedures in conjunction with dental implant placement 
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Study IV: Antibiotic utilization during bone augmentation procedures in conjunction 
with dental implant insertion 
 To investigate antibiotic prescription patterns among Swedish dentists carrying out 
bone-augmentation procedures with dental implant placement  
 To investigate the effect of national recommendations on antibiotic prescription 
patterns 
 To investigate the effect of antibiotic prophylaxis prescription on the occurrence of 
postoperative infections following bone-augmentation procedures 
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3 MATERIALS AND METHODS 
3.1 Formal permissions 
3.1.1 Ethical application 
Studies I & IV were approved by the Karolinska Institutet Regional Ethics Committee, Dnr No: 
2013/706-31/1, and 2016/609-31, respectively. Studies II & III did not require ethical approval 
since there were no patients involved. In Study I, informed consent was obtained from all 
participants prior to the study onset.  
3.1.2 Approval to perform a clinical pharmaceutical study 
For Study I, approval from the Drug Medical Agency, Uppsala, Sweden was obtained. This study 
is registered in ClinicalTrial.gov: NCT01829529, with EudraCT, number 2013-000405-23. 
3.2 INVESTIGATION OF MICROBIOLOGICAL CONSEQUENCES OF ANTIBIOTIC 
PROPHYLAXIS (STUDY I) 
3.2.1 Study population  
Study I included thirty-three healthy volunteers. An announcement at the Department of Dental 
Medicine, Karolinska Inistitutet, Stockholm, Sweden was made in order to recruit volunteers. 
Participants were excluded if they had taken antibiotics within the past three months, were 
pregnant, breastfeeding, taking probiotics, had a penicillin or aspartame (E951) allergy, or had 
phenylketonuria.  
3.2.2 Intervention and sample collection 
All participants underwent a thorough medical history. A 5 ml unstimulated salivary sample was 
obtained from fasting participants in the morning before drinking, brushing teeth, and/or smoking 
(day 1, control sample). Thereafter, all candidates received 2 g amoxicillin orally under strict 
observation. Samples taken on days 2 (24 hours), 5, 10, 17 and 24 were, after careful oral and 
written instructions, collected by the participants at home and promptly delivered to the Division 
of Clinical Microbiology, Institution of Laboratory Medicine, Karolinska Institutet, Stockholm, 
Sweden, and immediately stored at -70°C until analysis (Figure 3). 
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Figure 3. Collecting of saliva during study period 
3.2.3 Microbiological culture 
One ml saliva was added to a vial with 4 ml of VMGII buffer and diluted ten-fold in PBS (10-1 – 
10-5). A total of 0.1 ml from each dilution was inoculated onto selective agar plates (Mitis 
Salivarius agar (MS), Cystine lactose electrolyte deficient agar (CLED), Aesculin agar, Haematin 
agar, Sabouraud agar, Brucella agar with kanamycin and vancomycin (BKV), Brucella agar with 
neomycin and vancomycin (BNV), Rogosa agar, blood-agar plates containing 2 mg/ L 
amoxicillin, and non-selective agar plates (blood-agar) (Heimdahl and Nord 1979). The aerobic 
plates were incubated at 37°C for 24 hours, and the anaerobic plates were incubated at 37°C in 
an anaerobic jar for 48 hours. After incubation, the plates were examined and the different 
microorganisms counted for quantitative evaluation. Each bacteria type was re-isolated to obtain 
a pure culture. All isolates were examined by Gram-stain and colony morphology, and identified 
by matrix-assisted laser desorption ionization-time of flight mass spectrometry (MALDI-TOF 
MS) (Bruker Daltonik, Gmbh, Germany) (Angeletti, et al. 2015; Panda, et al. 2014). ≥ 2 log 
number of bacteria per ml saliva was considered as the level of detection for culturing. A 0-value 
was assigned for all date below this level.  
3.2.4 Antibiotic susceptibility tests 
The minimum inhibitory concentrations (MICs) were determined for strains isolated from 
antibiotic-containing agar using the agar-dilution method according to the Clinical and 
Laboratory Standards Institute (CLSI) (CLSI 2012a; CLSI 2012b). The following antimicrobial 
agents were tested: amoxicillin, penicillin-V, clindamycin, and metronidazole. Reference strains 
for MICs were: Escherichia coli ATCC25922, Staphylococcus aureus ATCC 29213, 
Enterococcus faecalis ATCC 29212, Bacteroides fragilis ATCC 25285, and Clostridium difficile 
ATCC 700057. The break-point was established according to the recommendations from the 
European Committee on Antimicrobial Susceptibility Testing (EUCAST) (www.eucast.org). In 
cases where EUCAST break-points were lacking, CLSI break-points were used. 
Day 1 
(Control 
sample)
2g amoxicillin  
(under 
observation)
Day 2 (24 
hour later)
Day 5
Day 10
Day 17
Day 24
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3.3 ANTIBIOTIC PRESCRIPTION PATTERNS AMONG SWEDISH DENTISTS 
WORKING WITH DENTAL IMPLANT SURGERY (STUDY II) 
3.3.1 Study design  
Study II is an observational questionnaire survey conducted in 2008 and 2012 and included 
dentists who placed more than 20 implants per year. The two time periods studied were before 
and after the publication of revised recommendations on the use of antibiotics by The Swedish 
Strategic Programme against Antibiotic Resistance (STRAMA) (Blomgren, et al. 2009), and a 
literature review of antibiotic prescription in conjunction with implant surgery by the Swedish 
Agency for Health Technology Assessment (SBU) (SBU 2010). An online search service of two 
Swedish telephone directories (www.hitta.se and www.eniro.se) using the key words “implant”, 
“dental clinic”, and “Stockholm region” was used to identify dental clinics in Stockholm region. 
Clinics were contacted by telephone to explain the study to the dentists. Questionnaires were sent 
with a prepaid envelope and a cover letter to explain the purpose of the study and to ensure 
confidentiality would be maintained. Reminder letters were sent to all included clinics 
Anonymous questionnaires were sent to 76 clinics in 2008. In 2012, the questionnaires were sent 
again to the same clinics that participated in 2008, and to additional new clinics established during 
the intervening period (in 2008, 120 dentists in 76 clinics participated, while in 2012, 161 dentists 
in 105 clinics participated). 
3.3.2 Questionnaire 
The questionnaire composed of two open and 10 closed questions. The first section included 
demographic data on gender, age, undergraduate training, number of years of clinical experience, 
implant surgical experience, and implant education. The second section asked about dentists’ 
routines used at the clinic and policies regarding antibiotic prescription prior to implant insertion, 
as well as local or systematic factors influencing prescription patterns. Two questions focused on 
the potential benefits from the establishment of national guidelines and interest in gaining 
information about antibiotic resistance.  
The 2012 questionnaire had five additional questions concerning respondents’ knowledge of the 
recent recommendations and scientific review from STRAMA (Blomgren, et al. 2009) and SBU 
(SBU 2010), and asked whether these had influenced their prescribing behavior. Data regarding 
antibiotic prescription regimens were extracted from the questionnaire. The data for those who 
prescribed antibiotics merely under special circumstances, such as medical or local surgical 
factors, was interpreted as not prescribing routinely. 
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3.4 METHODOLOGY FOR SCRUTINIZING THE LEVEL OF SCIENTIFIC 
PUBLICATION FOR USING ANTIBIOTICS AS A PROPHYLAXIS IN IMPLANT 
DENTISTRY WITH BONE AUGMENTATION PROCEDURES (STUDY III) 
3.4.1 Defining the review questions 
Study III is a complex systematic review conducted on studies including patients who underwent 
bone augmentation prior to, or in conjunction with dental implant surgery. Criteria for inclusion 
of reviews were that they needed to be a systematic review or systematic meta-analysis. Included 
primary studies needed to be randomized control trials (RCT) and contain an abstract in English. 
Exclusion criteria were any papers in a language other than English, German, French or Swedish. 
In addition, reviews were excluded if they were non-systematic, published as guidelines, a letter, 
position paper or consensus statement. Primary studies were also excluded if they were animal 
studies, in-vitro studies, were of any study design other than RCT, or lacking in follow up. The 
predefined study population, intervention, comparing therapies, and outcome parameters (PICO) 
for the eligible studies are summarized in Table 3. 
Table 3. A predefined study population, intervention, comparing therapies and outcome parameters (PICO), 
(Study IV)  
P Patients subjected to bone augmentation procedures with simultaneous or delayed implant 
placement 
I Antibiotics on day of surgery (short-term prophylaxis) 
Antibiotics more than day of surgery (extended prophylaxis) 
Head-to-head comparison of different antibiotic compounds or regiments 
C No antibiotic treatment 
Placebo 
Other non-antibiotic treatment e.g. such as antibacterial rinsing 
Other/comparing antibiotic treatment (alternative compound) 
Same compound, different dose/duration 
O Infection (primary) 
Quality of life (primary) 
Pain (primary) 
Implant loss 
Loss of transplant 
Sequestrum/sequestra 
Bone gain assessed by increased volume 
Health economy  
Ethical aspects 
3.4.2 Literature search 
Literature searches on the following databases were searched until October 20, 2015: Medline 
(OVID), The Cochrane Library (Wiley), EMBASE (embase.com), and PubMed (non-indexed 
articles). No filters were used during the initial search phase for primary studies. Thereafter, a 
search was performed with filters for systematic reviews. A complementary search was 
performed in PubMed on November 24, 2016 for additional recent publications. This additional 
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search did not use any filters. Health technology assessment (HTA) organisations were searched 
until October 30 2015: NICE, http://www.nice.org.uk/; CADTH, http://www.cadth.ca/; CRD 
database,http://www.crd.york.ac.uk/CRDWeb/; Kunnskapssenteret, 
http://www.kunnskapssenteret.no/home?language=english;ASERNIP-S, 
http://www.surgeons.org/for-health-professionals/audits-and-surgical-research/asernip-
s/publications/. The reference lists of all eligible studies were hand-searched for complementary 
studies.  
3.4.3 Assessing a study’s relevance 
The retrieved list of publications was reviewed to a crude exclusion of irrelevant publications 
based on title. Uncertain publications remained included until the next selection step. The next 
selection step was examination of the abstracts through independent reading by three reviewers 
in duplicate. All selected systematic reviews and primary studies were each read in full-text by 
three reviewers. In the case of disagreement during the screening process, a group discussion was 
undertaken.  
3.4.4 Assessing the quality and the scientific evidence of intervention 
studies  
No systematic reviews were included for quality assessment. The quality of the recruited primary 
studies were assessed using randomized studies assessment protocol (Guyatt, et al. 2011). The 
quality of scientific evidence in the primary studies was graded according to the Grading of 
Recommendations Assessment, Development and Evaluation (GRADE) and set as high, 
moderate, low or very low (Balshem, et al. 2011).  
3.4.5 Data extraction 
No systematic reviews were included for data extraction. For primary studies, data regarding 
number of included patients, age, gender distribution, length of follow-up, type of intervention, 
type of control treatment and relevant treatment outcomes were extracted. 
3.5 INVESTIGATION OF ANTIBIOTIC UTILIZATION DURING BONE 
AUGMENTATION PROCEDURES IN IMPLANT DENTISTRY (STUDY IV) 
3.5.1 Study design  
Study IV is a multicenter retrospective cross-sectional study, conducted during two time periods 
(2010-2011 and 2014-2015), reviewing the utilization of antibiotic prophylaxis in bone 
augmentation procedures in conjunction with dental implant placement. It includes four 
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specialized Swedish dental clinics performing implants with bone augmentation procedures. The 
two time periods were before and after the publication of the Swedish national recommendations 
on antibiotic prophylaxis in 2012 in order to determine the influence of the recommendations on 
antibiotic prescribing behavior (Läkemedelsverket 2012). The four clinics included were the 
Department of Periodontology at the Odontology Institution in Jönköping, the Department of 
Oral and Maxillofacial Surgery at the Odontology Institution in Jönköping, the Department of 
Oral and Maxillofacial Surgery at the Eastman Institute, Stockholm, and the Department of Oral 
and Maxillofacial Surgery at Södra Älvsborgs Sjukhus, Borås. Each clinic contributed with 100 
cases based on power calculation, 50 from each time period. Inclusion criteria were intraoral bone 
augmentation procedures performed on the indication of insufficient bone volume for immediate 
or later placement of dental implants. Patients below the age of 18 years, or those with incomplete 
or missing patient records were excluded from the study. Patients list were searched and retrieved 
by using treatment codes.  
3.5.2 Data collection 
Data regarding patient characteristics and general health, medications, allergies, smoking habits, 
risk factors for infection, and the surgeon’s type of training and education were obtained. In 
addition, type of surgical procedure, anatomical location, prescription of antibiotics, type of 
compound, dose and duration, choice of material used for bone augmentation, membrane used or 
not, sinus lift performed or not, and whether the implant was inserted immediately or not with 
bone augmentation procedure, were collected. All postoperative infections occurring during the 
first three months after surgery were registered, as well as how they were handled. Data were 
collected using a standardized case record form.  
3.6 DATA ANALYSIS 
Statistical analysis was performed using SPSS for Windows release 21.0 (SPSS Inc., Chicago, 
IL, USA). Absolute frequencies were used to describe the data. In Study III, statistical analysis 
was not applicable due to the few number of studies included.  
3.6.1 Sample size 
In Study I, a power calculation based on estimated data using the results from Chardin et al 2009 
(Chardin, et al. 2009), gives 80% power at P = 0.05 determined by a sample size of 30, plus an 
additional 10% to compensate for eventual drop out (n = 3). In the above-mentioned study, the 
base-line value for amoxicillin resistant streptococci was 1.3 %, while on day 9 after 3 days of 
MATERIALS AND METHODS 
 
25 
 
amoxicillin administration, the level was 23 %. This thus corresponds to a difference of 21.7% 
between test and control. 
In Study IV, a power calculation based on the hypothesis that 80% of the patients received 
prolonged antibiotic prophylaxis prior to the national recommendations, and 60% after, gave a 
total required sample size of 200 patients at 80% power and P = 0.05. Since this sample size 
calculation was based on a crude estimation it was decided to double the number to 400 patients. 
3.6.2 Wilcoxon signed rank test 
Changes in median log number of bacteria per ml saliva in Study I were compared to baseline 
values (day 1, control sample) using a Wilcoxon signed rank test. A P-value of ≤ 0.05 was 
considered statistically significant, while P-values ranging from 0.05-0.10 were interpreted as 
having a tendency towards a difference.  
3.6.3 T-test 
In Study I, changes in the proportion of bacteria with reduced susceptibility to amoxicillin were 
compared using a paired two-tailed t-test. A P-value of ≤ 0.05 was interpreted as statistically 
significant.  
In Study IV, an independent t-test was used to determine the differences between the two time 
periods (2010-2011, and 2014-2015). A P-value of ≤ 0.05 was considered statistically significant.  
3.6.4 Chi-square tests 
In Study II, a chi-square test was used to assess statistically significant differences. The level of 
significance was set to P ≤ 0.05. 
3.6.5 Pearson´s correlation 
In Study IV, the relationship between variables was tested using Pearson´s correlation coefficient. 
A P-value of ≤ 0.05 was considered statistically significant.  
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4 RESULTS 
4.1 MICROBIOLOGICAL CONSEQUENCES OF ANTIBIOTIC 
PROPHYLAXIS (STUDY I) 
There was no drop out from the study. However, due to incomplete collection of salivary samples, 
four volunteers were excluded. Therefore, 29 volunteers were included in the analysis, 14 males 
and 15 females, aged between 19-45 years with a mean age of 30 years. Eight of the volunteers 
reported a total of ten self-limiting adverse events during the study, including flu, chills, headache, 
diarrhea, xerostomia, muscular neck discomfort, and sore throat. 
A change in the distribution of oral microflora was shown throughout the study period (Table 4). 
A significant reduction in the number of viridans streptococci was reported, such as Streptococcus 
sanguis and Streptococcus anginosus on day 2 (P = 0.04), and Streptococcus salivarius on days 
2 and 5 (P < 0.001). Neisseria spp. significantly increased on day 2 (P = 0.02). There was a 
tendency towards a reduction in Micrococcus spp on days 2 and 17 (P = 0.06 and P = 0.09, 
respectively). There were no significant changes in any other aerobic species. Regarding the 
anaerobic microflora, Prevotella spp showed a tendency towards a reduction on days 5, 17, and 
24 (P = 0.09, P = 0.07, and P = 0.06, respectively). There were no significant changes in any other 
anaerobic species. 
There was a significant increase in the proportion of viridans streptococci with reduced 
susceptibility to amoxicillin on days 2 and 5 (P = 0.00 and P = 0.04, respectively). The MIC50 
for viridans streptococci isolated from amoxicillin-containing agar tested against amoxicillin 
were 4 mg/L on all days, while for MIC90 it was in the range of 4 to 256 mg/L (breaking point is 
2 mg/L) throughout the study period. The MIC50 for Prevotella spp isolated from amoxicillin-
containing agar tested against amoxicillin were 16 mg/L on all days except for day 24 where it 
was 8 mg/L. MIC90 was 64 mg/L on all days except for days 5 and 10 where it was 128 mg/L 
(breaking point is 2 mg/L). Therefore, the majority of viridans streptococci and Prevotella spp. 
selected from the amoxicillin-containing agar were resistant to amoxicillin and penicillin-V 
(Table 5).
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Table 4. Distribution of oral microflora throughout the study period 
 
 
Na Day 1 
M 
(min – max) 
Nb Day 2 
M 
(min – max) 
Nb Day 5 
M 
(min – max) 
Nb Day 10 
M 
(min – max) 
Nb Day 17 
M 
(min – max) 
Nb Day 24 
M 
(min – max) 
Nb 
Aerobic bacteria 
Streptococcus salivarius spp 29 16,8  
(10,1 - 19,1) 
29 12,6 
(0 – 18,1) 
23 13,1 
(6,9 – 18,8) 
29 16,11 
(7,82 – 19,11) 
29 15,76 
(9,62 – 18,83) 
29 16,1 
(5 – 20) 
29 
 
Other viridans streptococci 29 17,7 
(13,1 - 19,7) 
28 16,5 
(12,4 - 19,1) 
29 16,8 
(10,8 – 19,1) 
28 17,73 
(13,12 – 19,52) 
29 17,73 
(12,43 – 20,03) 
29 17,9 
(14,5 – 22,5) 
28 
 
Neisseria spp 25 15,8 
(9,2 – 17,4) 
18 15 
(10,8 – 20) 
25 15,4 
(7,3 – 17,7) 
19 16,12 
(11,51 – 18,83) 
21 14,22 
(7,31 – 17,73) 
22 15,4 
(9,2 – 18,4) 
21 
 
Micrococcus spp 9 16,8 
(14,4 – 20,0) 
9 15,5 
(13,1 – 16,5) 
7 13,8 
(11,5 – 17,7) 
8 17,03 
 (11,92 – 18,42) 
9 14.73 
(11,92 – 17,37) 
7 16,1 
(14,2 - 17,7) 
9 
 
Staphylococcus aureus  8 10,8 
(7,3 – 18,1) 
7 11,5 
(8,5 – 15,4) 
6 13,7 
(6,9 – 18,4) 
6 10,46 
(9,21 – 14,29) 
7 12,32 
(8,52 - 15,42) 
8 10,8 
(7,3 – 15,4) 
5 
 
Candidia spp 3 7,8 
(6,9 – 8,8) 
2 7,6 
(7,3 – 8,4) 
3 7,3 
(6,2 – 8) 
3 6,76 
(6,21 – 7,31) 
2 7,46 
(7,31 – 7,60) 
2 8,2 
(8 – 8,3) 
2 
 
Enterobacteriacae spp  3 9,4 
(8,3 – 10,8) 
3 7,3 
(7,3 – 7,3) 
2 8,1 
(7,6 - 8.5) 
2 10,82 
 
1 17,73 
 
 1 9 
(7,6 – 11,5) 
3 
 
Staphylococcus epidermidis  2 10,1 
 
1  0 15,1 
 
1 16,81 
 
1 12,8 
(8,52 – 17,03) 
2 17 
(16,5 – 17,4) 
2 
 
Haemophilus spp 1 11,9 
 
1  0  0 15,42 
 
1  0  0 
 
Cornybacterium spp 1  0 14,2 1 14,7 
 
1  0  0  0 
Enterococcus spp 1  0  0  0  0 9,2 
 
1 10,8 
 
1 
 
Anaerobic bacteria 
Prevotella spp 27 15,4 
(9,6 -19,7) 
26 13,8 
(8,3 - 19,1) 
27 14,5 
(6,9 – 19,3) 
20 13,5 
(8,5 – 19,1) 
25 13,8 
(6,9 – 18,4) 
24 13,5 
(6,2 – 19,3) 
27 
 
Leptotrichia spp 19 8,5 
(6,2 – 17,7) 
15 9,21 
(6,2 – 13,1) 
16 9,2 
(7,3 – 13,1) 
17 9,2 
(6,2 – 12,4) 
16 8,4 
(6,2 – 17) 
17 8,7 
(6,2 – 15,4) 
19 
 
Lactobacillus spp 13 8,3 
(5,30 – 10,82) 
13 9 
(7,3 – 17,7) 
13 8,5 
(4,6 – 10,6) 
12 8,9 
(6,2 – 9,2) 
12 7,6 
(6,2 – 10,1) 
13 8,5 
(6,2 – 10,8) 
12 
 
Fusobacteria spp 13 9,2 
(6,2 – 12,6) 
8 8,3 
(6,2 – 12,4) 
13 9,3 
(6,2 – 15,4) 
9 7,6 
(6,2 – 9,6) 
7 8,9 
(6,2 – 14,4) 
7 8,5 
(6,2 – 13,1) 
10 
 
Veillonella spp 8 17 
(9,2 – 19,1) 
8 14,7 
(13,1 – 17,7) 
4 14 
(6,9 – 17,5) 
7 17,5 
(15,4 – 18,4) 
5 15,4 
(8,5 – 20) 
6 12,3 
(8,5 – 15,4) 
5 
 
Anaerobic cocci spp 5 17,2 
(7,3 – 17,4) 
5 13 
 (12,6 – 13,4) 
2 13 
(10,1 – 13,8) 
3 13,5 
(10,8 – 16,1) 
4 11,3 
(6,2 – 17,7) 
3 10,2 
(4,6 – 16,5) 
4 
 
Actinomyces spp 3  0 14,5 
 
1 16,5 
 
1 10,8 
 
1 15,9 
 
1  0 
 
M, Median of log values of the number of microorganisms above the detection level per mL saliva.  
(minimum - maximum)   
Na, Number of patients with detectable levels of microorganisms within the sampling period. 
Nb, Number of patients with detectable levels of microorganisms at the actual sampling day. 
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Table 5. MIC50, MIC90, and the range of viridans streptococci and Prevotella spp, isolated from blood agar containing 2 mg/L amoxicillin 
Antibiotic                        Amoxicillin  Clindamycin  Penicillin-V  Metronidazole  
 MIC mg/L BP MIC mg/L BP MIC mg/L BP MIC mg/L BP 
 MIC 
50 
MIC 
90 
Range  MIC    
50 
MIC    
90 
Range  MIC 
50 
MIC 
90 
Range  MIC 
50 
MIC 
90 
Range  
Viridans streptococci 
Day 1 4     4 (4 - 4)  0,016 0,125 (< 0,016 –0,125)  
 
2 2 (0,5 – 2)  256 256 (128 – 256)  
Day 2 4    8 (0,25 – 8)  0,032 32 (< 0,016 – 32)  
 
2 4 (0,5 – 4)  256 256 (128 – 256)  
Day 5 4   16 (0,064 - 16)  0,016 16 (< 0,016 – 16)  
 
2 16 (0,5 – 16)  256 256 (128 – 256)  
Day 10 4   8 (0,064 - 8) 2 mg/L 0,032 32 (< 0,016 – 32) 0.5 
mg/L 
2 8 (0,5 – 8) 2 mg/L 256 256 (64 – 256) NA 
Day 17 4   16 (0,25 – 16)  0,125 256 (< 0,016 - 256)  
 
2 8 (0,125 – 8)  256 256 (256 – 256)  
Day 24 4  256 (0,25 - > 256)  0,125 256 (< 0,016 - > 256)  
 
2 256 (0,5 - >256)  256 256 (256 – 256)  
Prevotella spp  
Day 1 16 64 (0,032 - 256)  
 
0,032 0,064 (< 0,016 - > 256)  
 
2 8 (<0,016 -16)  1 4 (0,016 - 8)  
Day 2 16 64 (0,032 - 64)  0,032 256 (< 0,016 - > 256)  
 
4 16 (<0,016 - 16)  1 256 (0,250 - > 256)  
Day 5 16 128 (0,064 - 128)  0,016 0,064 (< 0,016 - 256)  
 
2 16 (<0,016 - 16)  1 8 (0,5 - 8)  
Day 10 16 128 (0,032 - 128) 2 mg/L 0,032 256 (< 0,016 - > 256) 
 
4 mg/L 2 8 (<0,016 - 16) 2 mg/L 1 4 (0,064 - > 256) 4 mg/ L 
Day 17 16 64 (0,032 - 64)  0,016 0,5 (< 0,016 - > 256) 
 
 2 4 (<0,016 - 4)  0,5 4 (0,125 - 8)  
Day 24 8 64 (0,032 - 128)  0,032 32 (< 0,016 - > 256)  
 
2 16 (<0,016 - 32)  0,5 8 (< 0,016 - 16)  
BP, Breaking points. 
NA, Not available. 
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In 21% (n = 6/29) of individuals, penicillin-V and amoxicillin resistant viridans streptococci were 
isolated before antibiotic taken. The carrier rate for amoxicillin resistant Prevotella spp. prior to 
antibiotic administration was reported in 59% (n = 17/29) of the volunteers, and the corresponding 
figure for penicillin-V resistance was found in 62% (n = 18/29). Throughout the study period, 
approximately one third of participants gained resistant viridans streptococci against amoxicillin, 
clindamycin, and penicillin-V. While in Prevotella spp., there was approximately 28% gain in 
resistance to all antibiotics tested (Figure 4).  
 
Figure 4. Percentages of individuals who gained resistant microorganisms after administration of 2 g amoxicillin 
(Khalil, et al. 2016). 
4.2 ANTIBIOTIC PRESCRIPTION PATTERNS AMONG SWEDISH DENTISTS 
WORKING WITH DENTAL IMPLANT SURGERY (STUDY II) 
The response rate for the distributed questionnaire in 2008 was 75% (n = 90), and 88% (n = 142) 
in 2012. Consequently, 85 questionnaires in 2008 and 133 in 2012 were included, after excluding 
five questionnaires in 2008 and nine in 2012 due to missing data concerning the use of antibiotics 
with dental implant placement. Males dominated amongst the participating dentists (79% in 2008; 
75% in 2012), and the majority of questioned dentists were in the age group of 55 years or older. 
The majority of dentists had completed their undergraduate education at a Swedish university 
(98% in 2008; 97% in 2012). Regarding their implant education, in 2008, 46% had received 
clinical postgraduate specialty training, while in 2012, 40% had. On the other hand, 54% reported 
they had participated in a single course in implant dentistry in 2008, while 60% had in 2012. 
Ninety-three percent of dentists in 2008, and 92% of dentists in 2012 replied that they had 
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received information regarding antibiotic usage during their implant education. More than half of 
the dentists questioned had worked in clinical practice for more than 20 years (65% in 2008; 60%, 
in 2012). Moreover, 53% had over 10 years of experience in implant surgery in 2008, with 64% 
in 2012. There were no significant differences in regard to the demographic data between the two 
years measured. However, dentists without specialty clinical training were significantly more 
prone to extend antibiotic prophylactic administration beyond the day of surgery (P < 0.01). 
There was a significant reduction in the number of routinely prescribed antibiotics between 2008 
and 2012 (P = 0.01) (Table 6). There was also a significant change in the type of antibiotics 
prescribed (P = 0.01). The majority of dentists in 2008 (67%) prescribed penicillin-V, and 21% 
prescribed amoxicillin. In 2012, 43% of dentists prescribed penicillin-V and 47% prescribed 
amoxicillin. Other antibiotics such as clindamycin and metronidazole were less frequently 
prescribed. There was a significant reduction between the two time periods in the number of 
dentists prescribing antibiotics beyond the day of surgery (P = 0.04). In 2012, 65% of the 
respondents prescribed a single dose of antibiotics, while 35% prescribed an antibiotic course for 
≥2 days. In 2008, 49% of the dentists prescribed single dose compared to 51% for ≥2 days (Figure 
5).  
Table 6. Antibiotic prescription pattern with dental implant placement in Study II, III 
Antibiotic prescription pattern Before 
recommendation 
N (%) 
After 
recommendation 
N (%) 
p-value 
Study II: (Dentists self-reporting)     
                    Yes 75 (88) 98 (74) 0.01 
                     No 10 (12) 35 (26) 
Study III: (Patients receiving AB)     
                    Yes 174 (87) 145 (72.5) 0.00 
                    No 26 (13) 55 (27.5) 
N, number of participants; AB, antibiotic;  
Study II, Antibiotic prescription pattern with dental implant placement;  
Study III, Antibiotic prescription pattern with dental implant placement associated with bone augmentation    
procedure. 
 
The majority of the dentists in 2008 reported the need for national recommendations regarding 
the use of antibiotics in implant surgery and more than half were interested in information about 
antibiotic resistance. For the additional questions in the 2012 survey, 58% of the respondents 
stated that they had read the recent publications on antibiotic prescription in implant dentistry, 
82% of those said they had benefited from the information, and 33% stated to have changed their 
antibiotic prescription pattern. Therefore, this data suggests that the dentists who read the 
publication were more likely to prescribe single dose antibiotics (P = 0.00).  
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Figure 5. Type and duration of dentists self-reporting antibiotic type and duration  
Others: clindamycin and metronidazole 
4.3 ANTIBIOTICS AS A PROPHYLAXIS IN IMPLANT DENTISTRY WITH BONE 
AUGMENTATION PROCEDURES:  A COMPLEX SYSTEMATIC REVIEW 
(STUDY III) 
The search resulted in a total of 1305 primary studies and systematic reviews for screening after 
deduplication. Flow-charts of the screening process for primary studies and systematic reviews 
are described in Figure 6. Abstract screening resulted in a total of six reviews, which were 
allocated for full-text inspection. All these reviews were then excluded because the studies were 
out of topic (n = 4), or not considered a systematic review (n = 2). Therefore, none were left for 
quality assessment. For the primary studies, ten papers were read in full-text. Consequently, six 
studies were then excluded, yielding four primary studies included for further analyses. The 
excluded studies were either a letter to the editor (n = 2), case series (n = 1), not in English (n = 
1) or out of topic (n = 2). 
On performing quality assessment and data extraction for the primary studies, two studies were 
found to have high risk of bias (Lee, et al. 2012; Lindeboom and van den Akker 2003) and were 
thus excluded from this review. The reasons for high risk of bias were short-comings in study 
design and uncertainties in the randomisation process. The two remaining primary studies were 
classified as moderate risk of bias (Lindeboom, et al. 2006; Lindeboom, et al. 2005) and were 
included in the current complex systematic review. They were assessed as having moderate risk 
of bias due to having no published study protocol, unclear blinding, unclear randomization and 
no reports of loss during the follow up. 
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Figure 6.  Flow chart for primary studies and systematic review. 
PS: primary studies, SR: systematic review, n: number of articles 
One of the two included primary studies, Lindeboom et al. 2005, compared a single dose of 
clindamycin 600 mg preoperatively followed by four doses of placebo tablets every six hours for 
24 hours, with the same preoperative dose followed by four doses of 300 mg every six hours for 
24 hours (Lindeboom, et al. 2005). This study resulted in two patients developing a postoperative 
infection at the receptor site in the single dose group, while three patients developed infections in 
the group treated with clindamycin for 24 hours (RR, 0.67). The second primary study, compared 
a single dose prophylaxis of two different types of antibiotic compounds (penicillin and 
clindamycin) (Lindeboom, et al. 2006). In this study, four patients developed a postoperative 
infection at the receptor site in the group treated with 2 g penicillin 1 hour preoperatively, while 
two patients developed infection in the group treated with 600 mg clindamycin 1 hour 
preoperatively (RR, 2.00), (Table 7). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
Records identified through database searching or 
other sources 
(PS: n = 1562, SR: n = 185) 
 
Records screened 
(PS: n = 1155, SR: n = 150) 
 
Full-text articles assessed for 
eligibility 
   (PS: n = 10, SR: n = 6) 
 
Studies assessed for risk of bias  
            (PS: n = 4, SR: n = 0) 
 
Studies included  
     (PS: n = 2, SR: n = 0) 
 
Records excluded  
(PS: n = 1145, SR: n = 144) 
 
 
 Full-text articles 
excluded, with reasons  
(PS: n = 6, SR: n = 6) 
 
 
 Records excluded  
(PS: n = 2, SR: n = 0) 
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Table 7. Characteristics, quality assessment and outcome of included primary studies with low or moderate risk of bias 
Included studies Population Study 
period 
Intervention Control Postoperative infection at receptor 
site 
Results 
     Intervention Control  
 
Lindeboom et al. 2005 
Netherlands 
 
N: 124  
 
Age:  18-59 years 
 
Gender (M/F): 50/74 
 
Augmentation: Onlay 
buccal bone graft   
 
Smokers: none 
(exclusion criteria) 
     
 
8 weeks 
 
600 mg clindamycin 1 
hour prior surgery –
placebo capsules every 
6 hour for 24 hours 
postoperatively   
 
600 mg clindamycin 1 
hour prior surgery –  
300 mg clindamycin 
every 6 hour for 24 
hours postoperatively 
 
2/62 
(3%) 
 
3/62 
(5%) 
 
RR  0.67 
 
Lindeboom et al. 2006 
Netherlands 
 
N: 150 
 
Age:  18-67 years 
 
Gender (M/F): 52/98 
 
Augmentation: Onlay  
buccal bone graft   
 
Smokers: none 
(exclusion criteria) 
     
 
8 weeks 
 
2 g penicillin 1 hour 
prior surgery   
 
600 mg clindamycin 1 
hour prior surgery  
 
4/75 
(5%) 
 
2/75 
(3%) 
 
RR  2.00 
N, number of patients; M/F, male/female; mg, milligram; g, gram; RR, risk ratio. 
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4.4 ANTIBIOTIC UTILIZATION DURING BONE AUGMENTATION PROCEDURES 
IN IMPLANT DENTISTRY (STUDY IV) 
In this study, 200 patient files were included in each time period. In 2010-2011, participants 
consisted of 44.5% males and 55.5% females, with a mean age of 55 years, while in 2014-2015 
participants consisted of 48.5% males and 51.5% females, with a mean age of 54 years. More 
than half of the recruited patients were healthy and not taking any medication (53.5% in 2010-
2011 and 58.5% 2014-2015). Smoking was recorded in 21% of the patients in 2010-2011, and in 
16.5% in 2014-2015. In 2010-2011, three patients were under bisphosphonate treatment. 
Dentists’ specialties included oral maxillofacial surgeons, periodontist, general dentist or resident 
in those specialties during the study. The majority were oral maxillofacial surgeons (51.5% in 
2010-2011 and 55% 2014-2015). There were no significant differences in regard to the 
demographic data between the two time periods studied. In 2014-2015, there was a weak 
significant relationship between the dentist under residency training programme and the practice 
of not prescribing antibiotics (P = 0.00, R = 0.19). 
The extent of the bone augmentation surgery varied from an area of one missing tooth (62% in 
2010-2011, 48% in 2014-2015) to a full arch (least common, 1% in both time periods). The 
majority of patients underwent autograft bone procedures during the study period (57.5% in 2010-
2011, 41% in 2014-2015). The frequency of other types of bone graft is presented in Table 8. In 
2010-2011, 25% of bone graft surgery cases were performed with sinus lift procedures and the 
same percentage were associated with placing resorbable membranes. In 2014-2015, 23% of 
cases were performed with sinus lift procedures, while the membranes were placed in 
approximately half of the patients (47%).  
Table 8. The distribution of the number and percentage the different bone grafts used during the two time 
periods. 
Type of bone graft: 2010-2011 
Before recommendation 
N (%) 
2014-2015 
After recommendation 
N (%) 
P-value 
 
Autograft 
 
115 (57.5) 
 
82 (41) 
 
0.00 
 
Xenograft 
 
66 (33) 
 
83 (41.5) 
 
NS 
 
Mixed (xenograft and autograft) 
 
 
19 (9.5) 
 
35 (17.5) 
 
0.02 
N, number; %, percentage, NS, non-significant 
This study showed that the number of patients not treated as recommended by the 2012 national 
guidelines of a single dose 2 g amoxicillin, was high and unchanged between the two time periods 
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(58%, and 57%, respectively). On the other hand, the total number of patients treated as 
recommended in the national guidelines significantly decreased (P = 0.02), (29% and 15.5%, in 
the two time periods, respectively). However, there was a significant reduction in the total number 
of antibiotics prescribed between the time periods (P = 0.00) (Table 6).  
Regarding the type of antibiotic prescribed, or deviation from the recommended dose, there was 
no significant difference comparing the two time periods. However, the most common antibiotic 
prophylaxis prescribed was penicillin-V (35%, and 49%, in the two time periods, respectively) 
(Figure 7). Antibiotic treatment duration for five to seven days remain constant and unchanged 
between the two time periods. Significant changes in antibiotic duration were reported when 
comparing the two time periods: the single prophylactic preoperative dose differed from that 
recommended, the extended prophylactic antibiotic dose on operation day increased (P = 0.03), 
while the ten-day antibiotic treatment duration decreased (P = 0.04), (Figure 8).  
 
Figure 7. The type of prescribed antibiotics in the two time periods  
Recommended: 2g amoxicillin preoperatively or 600 mg clindamycin according to Swedish guidelines published in 
October 2012 (Läkemedelsverket 2012). 
*Antibiotic type in dosage differ from the recommended 
Amox: Amoxicillin, Penicillin V: phenoxymethylpenicillin, other AB: amoxicillin or metronidazole or benzyl 
penicillin IV 
Before the publication of the Swedish guidelines, there was a positive correlation between 
membrane placement during bone augmentation procedures and antibiotic prescription (P = 0.03, 
R = 0.14). After the publication, there was a positive correlation between sinus lift procedure 
during bone augmentation surgeries and the prescription of antibiotics (P = 0.00, R = 0.31). 
Moreover, a significant inverse relationship between both the use of xenograft bone type and 
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number of missing teeth in the graft area, with antibiotic prescription was reported (P = 0.00, R 
= - 0.23, and P = 0.00, R = - 0.19, respectively). 
 
Figure 8. The duration of prescribed antibiotics in the two time periods  
Recommended: 2 g amoxicillin preoperatively or 600 mg clindamycin according to Swedish guidelines 
published in October 2012 (Läkemedelsverket 2012). 
Regarding the risk of developing postoperative infection following bone augmentation 
procedures, there was no significant difference found between the two time periods (P = 0.12). 
Postoperative infection was reported in seven patients in 2010-2011, and 14 patients in 2014-
2015 (Table 9), diagnosed within the first month after surgery. Of those 21 patients diagnosed 
with infection, 13 received no antibiotics, three received the recommended dosage and five were 
prescribed either different antibiotic type or duration. The relationship between not prescribing 
antibiotics and increasing the risk of postoperative infection was weak but significant (P = 0.00, 
R = 0.24). The patients who developed postoperative infections were treated either locally by 
irrigation (n = 2), with removal of the membrane (n = 3) or with removal of grafted bone or placed 
implant (n = 3). Systematic antibiotics were prescribed for the majority of the patients who 
developed the infection (n = 19). The antibiotics were either clindamycin (n = 3), penicillin-V (n 
= 11), amoxicillin (n = 3) or combination between penicillin-V and metronidazole (n = 2). 
Antibiotic duration for these patients were varied from 7 days up to 2 weeks.  
Table 9. The number of patients who developed postoperative infection.  
 
Postoperative infection 
 
 
2010-2011 
N (%) 
 
2014-2015 
N (%) 
P-value 
Yes 7 (3.5) 14 (7) 
0.12 
No 
193 (96.5) 186 (93) 
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5 DISCUSSSION 
5.1 MICROBIOLOGICAL CONSEQUENCES OF ANTIBIOTIC PROPHYLAXIS 
(STUDY I) 
The results show that a single-dose antibiotic prophylaxis (2 g amoxicillin) disturbs oral 
microflora and can result in resistant viridans streptococci in healthy individuals, peaking on 
day 2 (24 hours), and day 5 after administration. The relationship between antibiotic 
consumption and development of antibiotic resistance is well established (Foucault and 
Brouqui 2007; Livermore 2005). It has previously been suggested that short-term antibiotic 
treatments reduce the risk of developing antibiotic resistance (Guillemot, et al. 1998). However, 
research supporting this assumption is lacking and no previous studies have investigated the 
effect of a single-dose antibiotic prophylaxis on oral microflora for longer than 24 hours. Thus, 
due to the present results demonstrating a link between single-dose antibiotics and the 
development of antibiotic resistance, further research regarding whether it is safer to refrain 
even from short-term antibiotic prophylaxis use in many surgical fields is warranted. The 
weighing of the risk against benefits can then form a basis for solid recommendations regarding 
the use of antibiotic prophylaxis. Also, the necessary number needed to treat must be evaluated 
against any putative adverse effects. The results also show that approximately one third of 
participants gained resistant viridans streptococci against amoxicillin, clindamycin, and 
penicillin-V during the study period. Thus, it may be prudent to recommend caution when 
prescribing to healthy patients in order to avoid development of antibiotic resistance.  
The present study demonstrated that the greatest disturbance in viridans streptococci ecology 
occurred on day 2, 24 hours after administration of a single-dose antibiotic. The decrease in 
number of viridans streptococci has been reported in previous studies where amoxicillin was 
used for 3 to 7 days (Brismar, et al. 1993; Chardin, et al. 2009). A recent study showed a lack 
of significant changes on facultative anaerobic and streptococci in saliva prior to 24 hours after 
single-dose antibiotic administration (Larsson Wexell, et al. 2015). However, this study did not 
provide data after 24 hours so it is unknown whether similar changes would have been observed 
during a longer period. Although the present study indicated that ecological disturbance is 
short-term, peaking around day 2, this disturbance does occur during the highest risk period of 
acquiring a postoperative infection, which is during the first few days after surgery. Since the 
source of such infection is mainly endogenous (Heimdahl and Nord 1990), the risk of causative 
bacteria rendering treatment difficulty due to resistance therefore increases. Furthermore, the 
ecological disturbance increases the risk of acquiring and becoming colonized with antibiotic 
resistant bacterial strains (Nord 1990; Van der Waaij and Nord 2000).   
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In the current study, a significant increase in the proportion of viridans streptococci with 
reduced susceptibility to amoxicillin was detected after a single dose of amoxicillin. This may 
be due to pre-existing resistant strains, but below the detection level, being given the 
opportunity to multiply under antibiotic pressure, or actual newly colonizing strains developing 
due to ecological disturbance, or a combination of both. The increase in the number of resistant 
bacteria gives enhanced shedding and may thereby accelerate the dissemination of resistant 
strains. This could also mean that the protective efficacy of amoxicillin prophylaxis may be 
compromised. Understanding the process of resistance selection is becoming vital, considering 
the problem of growing antibiotic resistance. However, updated epidemiological data regarding 
carrier rates of resistant strains in the oral microflora are, to our knowledge, lacking. An 
interesting result in the current study is that the study participants were from a part of the world 
known to have one of the lowest rates of resistance (ECDC 2017), yet they exhibited relatively 
high commensal flora resistance carrier rates. This may imply that actual carrier rates of 
resistant viridans streptococci in the oral microflora are possibly greater than previously 
anticipated and may be gravely underestimated in countries where resistance is known to be 
higher.  
5.2 ANTIBIOTIC PROPHYLAXIS PRESCRIPTION PATTERNS IN IMPLANT 
DENTISTRY (STUDY II, STUDY IV) 
There was a wide variation in the type, dosage and duration of prophylactic antibiotic usage in 
conjunction with dental implant placement both in simple and complicated cases where bone 
augmentation was required. The results showed that the majority of dentists routinely 
prescribed prophylactic antibiotics prior to dental implant surgery. This finding is in agreement 
with other studies where 72% - 85.5% of the surveyed data, from Finland, India, the USA and 
the UK, routinely prescribed prophylactic antibiotics in conjunction with implant insertion 
(Datta, et al. 2014; Deeb, et al. 2015; Froum and Weinberg 2015; Ireland, et al. 2012; Pyysalo, 
et al. 2014). While the dentists’ survey concluded that they were influenced by scientific 
reviews, the results extracted from patients’ medical charts reported that the majority were 
treated with antibiotic doses, durations and types differing from that recommended by the 
national guidelines. One explanation is that the dental practitioners were more cautious and 
precise when answering the questionnaire but in practice they do not always follow clinical 
guidelines. In addition, investigators have recently discovered that dentists do not always keep 
themselves updated, despite the availability of information (Oberoi, et al. 2015; Palmer and 
Batchelor 2004). Even so, with scientific evidence regarding the use of prophylactic antibiotics 
in conjunction with implant surgery still inconclusive, the available information does not 
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provide the clinician with clear guidance. It may also be that the clinician, under certain 
circumstances, may prescribe antibiotics to protect the patient, and themselves, from treatment 
complications and any resulting financial consequences (Wardh, et al. 2009).  
In the results for both Studies II and IV, there was a significant increase in the number of 
patients treated without antibiotic prescription prior to dental implant treatement between the 
two time periods. This may either be due to the lack of solid evidence regarding the benefit of 
prescribing antibiotics to decrease the risk of postoperative infection/ implant failure, or that 
the dentists’ knowledge increased regarding the undesirable effects of the antibiotics they had 
been prescribing and they became more cautious. 
The more conservative approach to antibiotic prescription prior to dental implant placement 
was observed in the questionnaire filled in by dentists with postgraduate clinical training. 
Moreover, in the other study (Study IV) there was a significant but weak relationship between 
the dentists under residency training and restrictive antibiotic prescription. This may be due to 
dentists’, either under residency training or who had completed their training programmes, 
clinical training which focused on both the benefits and the undesirable effects of antibiotics. 
In a study testing the effect of a short-term antibiotic educational programme on dentists’ 
behaviors, promising results regarding antibiotic usage were shown (Öcek, et al. 2008).  
On comparing the two time periods, there was a noticeable change in the type of antibiotic 
prescribed as reported by the dentists’ questionnaire (Study II). Amoxicillin became the 
preferred drug of choice. Thus can be clarified by the implementation of the scientific reviews 
and recommendations that favour the prescription of amoxicillin preoperatively. Amoxicillin 
is widely used in conjunction with dental implant surgery, and its effect on reducing the risk of 
implant failures has been studied (Dent, et al. 1997; Laskin, et al. 2000). It has a good coverage 
of the oral microflora, moderate oral and gastrointestinal ecological effect, rapid and extensive 
oral absorption and therefore is a suitable choice for antibiotic prophylaxis in oral surgery. In 
the other study (Study IV), the patients’ medical charts show that the majority of the bone 
augmentation procedure patients took penicillin-V. In dentistry, penicillin-V is a widely 
prescribed and has several beneficial characteristics. It has a bactericidal action with a narrow 
spectrum, it is effective against most Streptococcus species and oral anaerobes, and it has a 
mild to moderate ecological effect when used to treat dental infections (Lund, et al. 2014; 
Resnik and Misch 2008).  
A change in antibiotic prescription duration was observed between the two time periods in the 
studies, reflecting the effect of the scientific reviews and national recommendation. More than 
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half the surveyed dentists reported that they prescribed a single preoperative dose post 
guidelines, rather than an extended regimen. Moreover, in the present study on bone 
augmentation surgery prior to dental implant placement, there was a dramatic reduction of the 
length of prophylactic antibiotic treatment. This could reflect the efforts to reduce antibiotic 
prescription as the clinician might not feel confident to refrain totally from extended 
prophylaxis. Therefore, this issue is still contradictory, with the need for providing 
recommendations based on sound scientific evidence. While great effort has gone into 
improving the guidelines in Sweden, solid information is still lacking. However, changing 
dentists’ antibiotic prescription behavior requires time. Therefore, a follow-up study is 
mandatory to check the influence of these recommendations and to remind practitioners to 
secure a professional attitude when prescribing antibiotics. 
The positive relationships between using resorbable membranes, sinus lift procedures and 
antibiotic prescription reported in the current bone augmentation study, to our knowledge, have 
not been observed in previous studies. The infection rate associated with these procedures is 
considered infrequent (Testori, et al. 2012). However, in a study that published a clinical 
consensus and recommendations for sinus lift procedures, the use of antibiotic prophylaxis for 
7 days to reduce the risk of infection was favoured (Testori, et al. 2012). Moreover, the present 
study reported that increasing the number of treated edentulous areas will increase the number 
of restrictive, no antibiotic prescriptions by dentists. Inserting several implants requires a larger 
mucoperiosteal flap, prolonged operating time, and poses a higher risk for wound 
contamination (Figueiredo, et al. 2015).  Explanations for our results could be that a dentist 
placing more than three implants is more confident with their surgical and aseptic techniques 
than other dentists performing single implant surgery, or this may just be a coincidence, or due 
to the small number of cases. Therefore, there is a need for further RCT to determine the reasons 
behind the influencing choice for antibiotic prescription. This would also form an important 
base for motivating dentists to be restrictive. 
Five percent of the patients who performed bone augmentation procedures prior to dental 
implant placement developed postoperative infections. In the current study, patients who were 
not treated with antibiotics had a weak significant relationship with the development of 
postoperative infection. This is probably due to the fact that this kind of surgery (clean-
contaminated surgery) carried a risk of infection, but this risk can be reduced with the use of 
prophylactic antibiotics (Olson, et al. 1984; Peterson 1990). However, since the rate of 
infection is low in relation to the sample size of the study, larger clinical studies are required to 
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confirm this result. To date, there is no gold standard for the treatment of postoperative 
infections, and thus probably explains the difference in dealing with this situation among 
implant surgeons. 
The majority of the dentists surveyed reported a need for the national guidelines to determine 
the need of antibiotics in implant surgery. The implementation of practice guidelines is 
expected to improve antimicrobial treatment behaviors, and reduce infection rates (Foucault 
and Brouqui 2007). Thus, strong scientific evidence are mandatory in the area of implant 
dentistry. It should be kept in mind that guidelines for antibiotic selection should be modified 
according to local factors, such as local resistant bacteria status, and professional realities 
(Mainjot, et al. 2009).   
5.3 ANTIBIOTICS AS A PROPHYLAXIS IN IMPLANT DENTISTRY WITH BONE 
AUGMENTATION PROCEDURES:  A COMPLEX SYSTEMATIC REVIEW 
(STUDY III) 
The systematic review identified only a few studies that met the inclusion criteria and illustrates 
the lack of scientific evidence regarding the effect of prophylactic antibiotics on oral bone 
augmentation procedures in conjunction with dental implant placement. Lindeboom et al. 2005 
showed that the number of postsurgical infections were few in both the single dose prophylaxis 
and 24-hour antibiotic dose groups. However, there was a 33% reduction, not statistically 
significant, in the risk of developing a postsurgical infection at the bone graft receptor site 
among patients who took a single dose of antibiotic prophylaxis compared to patients receiving 
a more extended 24-hour dose of clindamycin. In the Lindeboom et al. 2006 study, there was 
no significant difference in the risk of postsurgical recipient site infection on comparing two 
different single dose antibiotic prophylaxis compounds - penicillin and clindamycin. Therefore 
the results of a statistical comparison in both studies between the two groups may be hampered 
by insufficient power. Both studies indicated that wound infection rate using a single dose of 
prophylactic antibiotics was low. 
While there are many published systematic reviews regarding the beneficial effect of using 
antibiotics in dental implant surgery, none were found to fulfil the current study’s inclusion 
criteria. The two primary studies fulfilling the inclusion criteria were considered to be of 
moderate risk of bias (Lindeboom, et al. 2006; Lindeboom, et al. 2005). Therefore, definite 
conclusions regarding whether prolonged or single dose antibiotic prophylaxis is needed to 
reduce the risk of postoperative infection during bone grafting procedures cannot be drawn. 
Consequently, efficacy of antibiotic prophylaxis, regardless of its duration, compared to no use 
for prevention of postoperative infections after bone grafting procedures is needed.  
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Large numbers of systematic reviews are often seen in fields where primary studies are sparse 
and the results contradictory. Due to the lack of solid evidence, possibly from primary studies 
with few participants or low power, systematic reviews are often undertaken in an attempt to 
summarize and synthesize what data are available. Randomized clinical trials on the topic of 
antibiotics and bone augmentation procedures are lacking, thus there is a great need for high 
quality primary research in this field. The results of the present study serve to emphasize the 
fact that one needs to be vigilant about drawing conclusions from the current published 
systematic reviews in the field. 
It has been proven that clinicians are responsible for the link between treatment decisions and 
the problem of antibiotic resistance, via their prescribing behavior (Costelloe, et al. 2010). 
Antibiotic resistance is one of the biggest problems now facing healthcare providers. In 
addition to the diminishing number of new agents entering clinical practice (Bencharit 2012), 
such resistance is becoming a major threat to public health (WHO 2015). Recently, the World 
Health Organization reported that some common infections are becoming more difficult to 
manage and may need longer recovery period due to antibiotic resistant bacteria (WHO 2015). 
5.4 LIMITATIONS 
Study I: The purpose of this study was to investigate the effects of a single-dose antibiotic 
prophylaxis on normal oral microflora in terms of ecological composition and selection for 
resistance. The rate and selection of antibiotic resistance by MIC and culturing methods, with 
drawbacks of, for example, loss of uncultivable bacteria, were chosen. New sensitive molecular 
methods do not permit antibiotic sensitivity tests. Furthermore, DNA-based methods cannot 
discriminate between viable/non-viable bacteria and therefore hamper quantitative analysis.  
Study II: The questionnaire distributed in this study has not been formally validated. However, 
the results showed that recommendation and postgraduate clinical training are important in 
restricting antibiotic usage in dental implant surgery. Since the responses to the questionnaires 
were anonymous, it was not possible to analyze changes in individual dentist behaviors 
between the two time periods. 
Study III: In this complex systematic review, it was not possible to perform a meta-analysis to 
draw a definite conclusion since there were only a limited number of studies that fulfilled the 
inclusion criteria. However the results of this study highlight the need for scientific based 
evidence. 
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Study IV: This is a retrospective study design. Therefore, there are limitations in obtaining the 
exact description for each augmentation procedure. Thus can slightly compromise the accuracy 
of the data but this design allowed the inclusion of a large number of patients.
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6 CONCLUSIVE REMARKS 
Study I: A single dose of 2 g amoxicillin induced the selection of bacterial resistance and caused 
ecological disturbances in normal oral microflora and therefore supports a restrictive approach 
regarding antibiotic prophylaxis. 
Study II: There was a wide variation in the type, dose and duration of antibiotics prescribed by 
dentists prior to routine dental implant procedures. A reduction in antibiotic prescription of a 
single dose prophylaxis was observed on comparing the two time periods. This leads support 
to the fact that scientific reviews and recommendations have influenced dentist antibiotic 
prescription behavior. 
Study III: There are a limited number of scientific studies containing evidence regarding the 
use of antibiotic prophylaxis to reduce the risk of infection in conjunction with bone 
augmentation procedures prior to dental implant placement. This review showed that the 
infection rate using a single dose antibiotic prophylaxis was low. However, the infection rate 
is still unknown in comparison to non-usage of prophylactic antibiotics. Therefore, this study 
supports the need for further primary randomized controlled studies to evaluate the benefit of 
antibiotic prophylaxis in conjunction with bone augmentation procedures prior dental implant 
placement. 
Study IV: Misuse and overuse of antibiotics during bone augmentation procedures prior to 
dental implant placement was observed. Large variations between observed and recommended 
practices were seen. A weak relationship was observed between the risk of developing 
postoperative infection after bone augmentation surgery prior to dental implant placement, and 
no antibiotic prophylaxis prescribed. Therefore, strict, solid guidelines based on scientific 
evidence are mandatory to improve dentists’ prescription behaviour.
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7 FUTURE PRESPECTIVES AND RECOMMENDATIONS 
Today, the use of antibiotics in medical practice is an important subject that needs to be 
understood. While there is a beneficial effect from antibiotic use, side effects are reported. 
Recently, there has been an increase in prophylactic antibiotic prescriptions, even without any 
evidence to indicate that such use of prophylactic antibiotics would decline the risk of 
postoperative infection. With the increasing emergence of antibiotic resistance, it is necessary 
to limit antibiotic use. There is a lack of scientific evidence on the beneficial effect of 
prophylactic antibiotics in the literature, and consequently no solid recommendations on the 
use of antibiotics in simple or complicated dental implant surgical cases. In addition, the effect 
of antibiotic prophylaxis in human microflora needs to be further investigated. Therefore, well-
designed RCTs with larger sample sizes and longer follow-up periods are essential to be able 
to assess the benefit risk ratio in using antibiotic prophylaxis during implant insertion. Such 
studies should be reported according to the Consolidated Standard of Reporting Trials 
(CONSORT) guidelines (Moher, et al. 2001) and should evaluate treatment safety, efficacy 
and cost-effectiveness. The growing number of RCTs published over the last few years, and 
fulfilling these criteria positively indicate that we might finally reach ‘evidence based 
medicine’ rather than a traditional ‘opinion based’ approach to clinical decision making 
(Esposito, et al. 2009). Moreover, the need to spread the knowledge regarding the use of 
antibiotics and their desirable effects to all healthcare providers is mandatory. It has been 
reported that cooperation between countries has led to success in the fight against 
communicable diseases such as smallpox, polio, tuberculosis and measles. Initiative strategies 
have been taken by international associations and by governments and experts in individual 
countries in order to contain antibiotic resistance. The only way we can secure a future with 
effective antibiotics is through working together, and this should begin now. The WHO clearly 
states: No action today, no cure tomorrow. Therefore, there is a need to establish strict 
guidelines to improve the utilization of antibiotics in the dental implant field. These guidelines 
should prevent the risk of infection through better surgical intervention, decrease the risk of 
resistant bacterial strains developing, reduce total antibiotics usage, and possibly reduce the 
cost of care. It also should be as simple and specific as possible rather than attempting to cover 
all clinical situations (Durack 1995).
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